PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Cinnamic acid derivatives from P. mahaleb exhibit anti-tyrosinase and antimelanogenic effects in B16F10 murine melanoma cells [PMID:36924865]
Concentrated fruit extract blunts pathological signs of chemically induced colitis and increases antioxidant defenses in mouse colon [PMID:31410984]
Seed extract was evaluated for its effect on ethylene glycol- and ammonium chloride-induced urolithiasis in mice [PMID:32210490]
Seed oil demonstrates antifungal activity and shows an indifferent effect when combined with fluconazole [PMID:34382873]
Water extract inhibits COX-2, TNF-alpha, HIF1-alpha, and VEGFA in isolated mouse colons [PMID:34361576]
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 33365475 (2019) — Complete chloroplast genome sequence of Prunus mahaleb. · Mitochondrial DNA. Part B, Resources
- 2.PMID: 37663279 (2023) — Profiling of primary and phytonutrients in edible mahlab cherry (Prunus mahaleb L.) seeds in the context of its different cultivars and roasting as analyzed using molecular networking and chemometric tools. · PeerJ
- 3.PMID: 31421756 (2019) — Exploitation of Prunus mahaleb fruit by fermentation with selected strains of Lactobacillus plantarum and Saccharomyces cerevisiae. · Food microbiology
- 4.PMID: 36924865 (2023) — Anti-tyrosinase and antimelanogenic effect of cinnamic acid derivatives from Prunus mahaleb L.: Phenolic composition, isolation, identification and inhibitory activity. · Journal of ethnopharmacology
- 5.PMID: 34361576